| GEMP Market Cap History Table | ||||||||||||||||||||||||||||||
Below is a table of the GEMP market cap history going back to 9/9/2016:
Also see: GEMP Shares Outstanding History and GEMP YTD Return |
GEMP Market Cap History — Gemphire Therapeutics Capitalization Over Time
As of 11/6/2019 Gemphire Therapeutics has a market cap of 5.67 million. Investors often follow the GEMP market cap history to compare the size of the company over time.
This page shows GEMP market capitalization trends over time, with 14 market cap datapoints presented, dating back to 9/9/2016.
| GEMP Market Cap History Chart | |||||||||||||||||||||||||||||||
GEMP Historical Market Cap: -61.44% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||
| GEMP Stock Price Chart |
| About NeuroBo Pharmaceuticals Inc |
| Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a medical condition that increases the risk of life-threatening cardiovascular disease, focused on orphan indications, as well as nonalcoholic fatty liver disease. Co.'s product candidate, gemcabene, has been tested as monotherapy and in combination with statins and other drugs. Within dyslipidemia, indications include Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia and Nonalcoholic Steatohepatitis. We show 14 historical shares outstanding datapoints in our GEMP shares outstanding history coverage, used to compute GEMP market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing GEMP market cap history over the course of time is important for investors interested in comparing GEMP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of GEMP versus a peer is one thing; comparing GEMP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like GEMP can fluctuate over the course of history. With this page we aim to empower investors researching GEMP by allowing them to research the GEMP market cap history. |
| GEMP Current Stock Quote |
Quotes delayed 20 minutes  Free GEMP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| GEMP Share Performance |
| Market Cap Peers |
| Gemphire Therapeutics (GEMP) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
GENE Market Cap History GERN Market Cap History GFOR Market Cap History GH Market Cap History GHDX Market Cap History GILD Market Cap History GKOS Market Cap History GLSI Market Cap History GLTO Market Cap History GLUE Market Cap History More Healthcare companies » |
GEMP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
